Literature DB >> 16174716

Tissue thyroid hormone levels in critical illness.

Robin P Peeters1, Serge van der Geyten, Pieter J Wouters, Veerle M Darras, Hans van Toor, Ellen Kaptein, Theo J Visser, Greet Van den Berghe.   

Abstract

CONTEXT: Pronounced alterations in serum thyroid hormone levels occur during critical illness. T3 decreases and rT3 increases, the magnitudes of which are related to the severity of disease. It is unclear whether these changes are associated with decreased tissue T3 concentrations and, thus, reduced thyroid hormone bioactivity. PATIENTS AND STUDY QUESTIONS: We therefore investigated, in 79 patients who died after intensive care and who did or did not receive thyroid hormone treatment, whether total serum thyroid hormone levels correspond to tissue levels in liver and muscle. Furthermore, we investigated the relationship between tissue thyroid hormone levels, deiodinase activities, and monocarboxylate transporter 8 expression.
RESULTS: Tissue iodothyronine levels were positively correlated with serum levels, indicating that the decrease in serum T3 during illness is associated with decreased levels of tissue T3. Higher serum T3 levels in patients who received thyroid hormone treatment were accompanied by higher levels of liver and muscle T3, with evidence for tissue-specific regulation. Tissue rT3 and the T3/rT3 ratio were correlated with tissue deiodinase activities. Monocarboxylate transporter 8 expression was not related to the ratio of the serum over tissue concentration of the different iodothyronines.
CONCLUSION: Our results suggest that, in addition to changes in the hypothalamus-pituitary-thyroid axis, tissue-specific mechanisms are involved in the reduced supply of bioactive thyroid hormone in critical illness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174716     DOI: 10.1210/jc.2005-1013

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling.

Authors:  Johannes W Dietrich; Patrick Müller; Fabian Schiedat; Markus Schlömicher; Justus Strauch; Apostolos Chatzitomaris; Harald H Klein; Andreas Mügge; Josef Köhrle; Eddy Rijntjes; Ina Lehmphul
Journal:  Eur Thyroid J       Date:  2015-05-23

2.  Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.

Authors:  Olga Barca-Mayo; Xiao-Hui Liao; Caterina DiCosmo; Alexandra Dumitrescu; Liliana Moreno-Vinasco; Michael S Wade; Saad Sammani; Tamara Mirzapoiazova; Joe G N Garcia; Samuel Refetoff; Roy E Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Modulation by thyroid hormone of myosin light chain phosphorylation and aquaporin 5 protein expression in intact lung.

Authors:  Naser Pajouhi; Mohammad Owji; Fakhraddin Naghibalhossaini; Gholam H R Omrani; Masoumeh Varedi
Journal:  J Physiol Biochem       Date:  2015-02-04       Impact factor: 4.158

4.  Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Authors:  Yves Debaveye; Björn Ellger; Liese Mebis; Theo J Visser; Veerle M Darras; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

6.  N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial.

Authors:  Josi Vidart; Simone Magagnin Wajner; Rogério Sarmento Leite; André Manica; Beatriz D Schaan; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

7.  Myocardial Inactivation of Thyroid Hormones in Patients with Aortic Stenosis.

Authors:  Bruno S Paolino; Pablo M Pomerantzeff; Luís Alberto O Dallan; Fabio A Gaiotto; Nailliw Z Preite; Ana Claudia Latrônico; José Carlos Nicolau; Antonio C Bianco; Roberto R C V Giraldez
Journal:  Thyroid       Date:  2017-04-12       Impact factor: 6.568

8.  The non-thyroidal illness syndrome in acute coronary syndrome is associated with increased cardiac morbidity and mortality.

Authors:  J Adawiyah; A W Norasyikin; N H Mat; A S Shamsul; K Nor Azmi
Journal:  Heart Asia       Date:  2010-07-06

9.  High prevalence of non-thyroidal illness syndrome in patients at long-term care facilities.

Authors:  Joaquin Lado-Abeal; Carmen Diaz; Gilbert Berdine; Kenneth Iwuji; David Araujo-Vilar; Natalia Lampon-Fernandez; Min Wang; Santiago Lojo; Alfonso Rodriguez-Perez; Ana Marcella Rivas
Journal:  Endocrine       Date:  2020-04-28       Impact factor: 3.633

Review 10.  Nonthyroidal illness syndrome in children.

Authors:  Seth D Marks
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.